disopyramide

DRUG2 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Uppsala University Hospital

Conditions

ArrhythmiaAtrial FibrillationCardiovascular DiseasesHeart DiseasesQuality of Life

Phase 3

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

CompletedNCT00000556

National Heart, Lung, and Blood Institute (NHLBI)Arrhythmia, Atrial Fibrillation, Cardiovascular Diseases +1

Start: 1995-03-31End: 2002-09-30Updated: 2016-03-25

Unknown Phase

Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)

Uppsala University HospitalAtrial Fibrillation, Quality of Life

Start: 2008-05-31End: 2018-09-30Updated: 2017-05-09

Related Papers

Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation

Hypertension2017-10-0431 citations